TrialLancet (London, England)2018

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

Alberto Papi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.